CAPITAL AND CODEINE Drug Patent Profile
✉ Email this page to a colleague
When do Capital And Codeine patents expire, and what generic alternatives are available?
Capital And Codeine is a drug marketed by Actavis Mid Atlantic, Valeant Pharms Llc, and Carnrick. and is included in three NDAs.
The generic ingredient in CAPITAL AND CODEINE is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Capital And Codeine
A generic version of CAPITAL AND CODEINE was approved as acetaminophen; codeine phosphate by WES PHARMA INC on June 27th, 2019.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CAPITAL AND CODEINE?
- What are the global sales for CAPITAL AND CODEINE?
- What is Average Wholesale Price for CAPITAL AND CODEINE?
Summary for CAPITAL AND CODEINE
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Patent Applications: | 4 |
DailyMed Link: | CAPITAL AND CODEINE at DailyMed |
US Patents and Regulatory Information for CAPITAL AND CODEINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Mid Atlantic | CAPITAL AND CODEINE | acetaminophen; codeine phosphate | SUSPENSION;ORAL | 085883-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Valeant Pharms Llc | CAPITAL AND CODEINE | acetaminophen; codeine phosphate | SUSPENSION;ORAL | 086024-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Carnrick | CAPITAL AND CODEINE | acetaminophen; codeine phosphate | TABLET;ORAL | 083643-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |